Business Description
Anebulo Pharmaceuticals is a Texas-based drug development company focused on helping people who experience serious adverse reactions to cannabis. Its primary drug in development, selonabant, works by blocking a specific receptor in the body that cannabis activates, and is currently being tested in human trials as a potential antidote. Founded in 2020, the company is working to fill a gap in emergency medicine where no approved treatment currently exists for severe cannabis-related episodes.
